New recommendations seek to reduce consumption of sugar, alcohol in U.S. diets
July 15, 2020 Dr. Beth Mayer-Davis is part of the Dietary Guidelines Advisory Committee, which has released new recommendations that aim to reduce the overconsumption of added sugars and alcohol in American diets.
Leading maternal health advocacy groups tackle barriers to equitable maternity care for women and families of color
July 14, 2020 $4 million in Coronavirus Aid, Relief and Economic Security Act funding will support COVID-19 related telehealth access and infrastructure for maternal health services.
Gillings faculty urge World Health Organization to address potential airborne spread of COVID-19
July 14, 2020 Drs. Barbara Turpin, Glenn Morrison and Jason Surratt from the Department of Environmental Sciences and Engineering have joined more than two hundred scientists in signing an open letter to the World Health Organization expressing concern about the potential airborne spread of COVID-19.
The Gillings Community Responds to COVID-19: Local Leadership with Statewide Impact
July 13, 2020 Public Health Leadership Program alumnus William Ray shares how his experience at Gillings eventually led him to a career managing an emergency response right here in our home state and the challenges that come with coordinating public health and public safety efforts in the midst of a pandemic.
Harvey Award will support mobile app for well-water testing
July 10, 2020 The Harvey Award recognizes exemplary faculty who reflect UNC's commitment to innovative engagement and outreach that addresses real-world challenges.
New study supports remdesivir as COVID-19 treatment
July 9, 2020 Researchers at the University of North Carolina at Chapel Hill, Vanderbilt University Medical Center and Gilead Sciences report that remdesivir greatly inhibited SARS-CoV-2, the virus that causes COVID-19, in human lung cell cultures and also improved lung function in mice infected with the virus.
LaVange on front lines of effort to develop drugs for COVID-19
July 6, 2020 The National Institutes of Health have launched a public-private partnership to identify effective treatments for COVID-19. Dr. Lisa LaVange of the Gillings School is supporting two committees in the partnership.
Seven new Gillings Innovation Labs will tackle COVID-19
July 6, 2020 Exactly how does coronavirus spread in the air? What will get kids’ vaccinations back on track across the United States? How can public health practitioners work with church communities to spread accurate information about COVID-19? These are just three of the questions being explored by Gillings School researchers and their collaborators through a special COVID-19 round of Gillings Innovation Laboratory awards.
Groundbreaking study reveals genetic markers for Type 2 diabetes in East Asians
July 6, 2020 A recent study — the largest of its kind in any non-European population — demonstrates that while different populations of people share similar genetic predispositions for Type 2 diabetes, they also have some genetic variations that can alter their susceptibility to developing the disease.
Koonin, an original 'architect of social distancing,' develops guidance for COVID-19 response
June 29, 2020 In January, the U.S. Centers for Disease Control and Prevention asked Gillings School alumna and adjunct faculty member Dr. Lisa Koonin, one of the "architects of social distancing," to develop guidance for the health system's response to COVID-19.
